David Bajor, MD - Closed

Iris Sheng, MD, is a hematologist and oncologist at University Hospitals Seidman Cancer Center. She practices at both at the main campus in Cleveland and in Avon, Ohio, where she specializes in the diagnosis and treatment of genitourinary cancer and skin cancer. Dr. Sheng is board certified in hematology, medical oncology and internal medicine and is a Clinical Assistant Professor at Case Western Reserve University School of Medicine.

Melinda Hsu, MD is a highly regarded specialist in Hematology and Oncology, with a primary location at 11100 Euclid Ave in Cleveland, OH. She is an Assistant Professor at the CWRU School of Medicine and is certified by the American Board of Internal Medicine in Internal Medicine. Dr. Hsu completed her fellowship in Medical Oncology at Johns Hopkins Hospital and her residency in Internal Medicine at Indiana University Hospital. She received her medical education from the University of Cincinnati College of Medicine and holds additional degrees from Georgetown University and Harvard University. With a patient experience rating of 4.9 out of 5 based on 45 reviews, Dr. Hsu is known for her informative, compassionate, and empathetic approach to patient care. She takes the time to involve patients and their families in the plan of care and ensures their safety. Dr. Hsu's expertise and dedication make her a trusted provider in the field of Hematology and Oncology.Generated from the website

Dr. Ankit Mangla is a medical oncologist at University Hospitals Seidman Cancer Center, specializing in the treatment of melanoma and rare tumors, including Merkel cell cancer and soft tissue sarcoma. He is dedicated to developing patient-centric treatment plans that minimize toxicity while maximizing efficacy, and serves as the Co-Director of the Sarcoma and Cutaneous Oncology Team. With a robust background in clinical research, Dr. Mangla has authored numerous papers in prestigious medical journals and participates in several oncology consortia focused on drug development. His commitment to advancing cancer treatment is reflected in his role as a principal investigator for multiple clinical trials aimed at improving outcomes for patients with melanoma and soft tissue sarcomas. Generated from the website